-5%
Injection Manufacturer/Distributor: Square Pharmaceuticals Ltd. Generic Name: Filgrastim 300 mcg/ml
Filgrastim is indicated to those:
- Cancer patients receiving myelosuppressive chemotherapy
- Patients with Acute Myeloid Leukemia receiving induction or consolidation chemotherapy
- Cancer patients receiving bone marrow transplant
- Patients with severe neutropenia
- Peripheral blood progenitor cell collection and therapy
